Suchergebnisse - "Attwood, Marie"

PubPharm (23)

1

In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

enthalten in: Microbiology spectrum | 2024

von Santerre Henriksen, A. | Jeannot, K. | Oliver, A. | +55

2

Development of antibacterial drug plus bacteriophage combination assays

enthalten in: bioRxiv.org | 2024

von Attwood, M. | Griffin, P. | Noel, A. | +4

3

Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Attwood, M. | Griffin, P. | Noel, A. | +2

4

Cefepime pharmacodynamic targets against Enterobacterales employing neutropenic murine lung infection and in vitro pharmacokinetic models

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Muller, A. | Attwood, M. | Van den Berg, S. | +4

5

Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Pantel, L. | Guérin, F. | Serri, M. | +9

6

Letter to the Editor : Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care

enthalten in: Microbial drug resistance (Larchmont, N.Y.) | 2022

von MacGowan, A. | Hamilton, F. | Bayliss, M. | +8

CommentOn: Ann Intern Med. 2020 Oct 20;173(8):670-672. - PMID 32422065

7

Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Noel, A. | Attwood, M. | Bowker, K. | +2

8

Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19

enthalten in: Wellcome open research | 2022

von Frost, J. | Hamilton, F. | Arnold, D. | +14

9

Predicting outcomes of COVID-19 from admission biomarkers : a prospective UK cohort study

enthalten in: Emergency medicine journal : EMJ | 2021

von Arnold, D. | Attwood, M. | Barratt, S. | +9

10

Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complications

enthalten in: EJHaem | 2021

von Mankelow, T. | Singleton, B. | Moura, P. | +19